The constantly expanding population of heart failure (HF) patients over the last few decades
in cardiology practice has successfully compelled cardiovascular (CV) research to evolve …

SGLT2 Inhibitors Are Lifesavers in Heart Failure - Heart Failure Clinics Skip to Main Content
Advertisement Heart Failure Clinics Log in Register Log in Subscribe Claim Skip menu …

Background: Sodium-glucose cotransporter 2 (SGLT2) inhibitors have shown promise in
improving cardiovascular outcome in patients with heart failure (HF) and diabetes mellitus …

Sodium-glucose co-transporter 2 (SGLT2) inhibitors are a relatively new class of
antihyperglycemic medication that are well established for the management of type-2 …

Abstract Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a type of per oral
antihyperglycemic medicine. It works by reducing glucose reabsorption in the proximal renal …

Introduction: In individuals with type 2 diabetes mellitus, sodium–glucose cotransporter 2
(SGLT2) inhibitors reduce the risk of hospitalization for heart failure and serious adverse …

More than 60 million people are living with heart failure (HF) worldwide and as many as one-
third may die within the next year. 1, 2 Immense progress has been made in the discovery of …

Heart failure remains a leading cause of hospitalization and death, and presents a
significant challenge for healthcare providers despite the advancements in its management …

Abstract Sodium-glucose co-transporter 2 (SGLT-2) inhibitors are the latest addition to
guideline-directed medical therapy in heart failure (HF) with reduced ejection fraction with …

More recently, the SGLT2i has demonstrated an un-expected significant and consistent
effect in patients with HFrEF. The serendipity of these drugs started with the evidence of the …